Author Archives: Christine Slattery

We Put the VIVA in LAS VEGAS — Don’t Miss LongevityFest 2025!

The countdown is on to the world’s largest anti-aging conference: LongevityFest 2025. In just a few days, the Venetian Convention & Expo Center in fabulous Las Vegas will become the epicenter of anti-aging solutions, longevity science, and health optimization, with the most innovative thinkers and the brightest medical minds coming together to forecast the future of health and aging and unlock the secrets of a longer, healthier life.

Longevity NOW!

According to a recent U.S. Census Bureau report, centenarians accounted for 2 out of 10,000 people in 2020. It’s an intriguing fact, especially in a world where health practitioners must work with aging and often unhealthy populations, face chronic medical conditions, widespread epidemics, overburdened healthcare systems, and even staff and supply shortages. The potential for long-term health and well-being lies in unlocking it, and the longevity industry has the passion and fervor to discover the key.

Continue reading

The FDA Removes Its Black Box Warning on Hormone Therapy: What Does It Mean for Longevity?

After more than two decades, the U.S. Food and Drug Administration (FDA) is initiating the removal of broad “black box” warnings from hormone replacement (HRT) products for menopause. The decision to update the FDA’s position follows a comprehensive review of the scientific literature, an acknowledgement of the expert panel’s findings in July, and a public comment period.

Now, the agency is collaborating with companies to update product labeling to remove references to the risks of cardiovascular disease, breast cancer, and probable dementia, acknowledging that HRT’s risks are not uniform—they vary based on patient factors, delivery method, and formulation.

Continue reading

Unlocking the Immune Code Leads to Better Outcomes…and a Nobel Prize

It’s the body’s first line of defense, shielding us from harmful microbes, viruses, and other invaders that attack and cause illness. But sometimes the human immune system fails or turns on itself to attack healthy cells and promote autoimmune diseases, like cancer, rheumatoid arthritis, and type 1 diabetes. For three scientists who conducted fundamental research on peripheral immune tolerance, a system that slows down the immune system and keeps it from harming the body, the result was a wealth of knowledge — and the 2025 Nobel Prize in Physiology or Medicine.

Continue reading